Lv1
10 积分 2024-07-24 加入
Efficient and Safe In Vivo Treatment of Primary Hyperoxaluria Type 1 via LNP-CRISPR/Cas9-mediated glycolate oxidase disruption
3小时前
求助中
Efficient and Safe In Vivo Treatment of Primary Hyperoxaluria Type 1 via LNP-CRISPR/Cas9-mediated glycolate oxidase disruption
1天前
已完结
Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins
3个月前
已完结
Atherosclerosis: Recent developments
5个月前
已完结
Intestinal Nogo-B reduces GLP1 levels by binding to proglucagon on the endoplasmic reticulum to inhibit PCSK1 cleavage
5个月前
已完结
Intestinal Nogo-B reduces GLP1 levels by binding to proglucagon on the endoplasmic reticulum to inhibit PCSK1 cleavage
5个月前
已关闭
Atherosclerotic Plaque Healing
5个月前
已完结
Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis
5个月前
已完结
Effective prevention of atherosclerosis by non-viral delivery of CRISPR/ Cas9
5个月前
已完结
Effective prevention of atherosclerosis by non-viral delivery of CRISPR/Cas9
5个月前
已完结
皖公网安备34019202002308
